| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Myocytes, Cardiac | 12 | 2024 | 674 | 1.990 |
Why?
|
| Adaptor Proteins, Signal Transducing | 7 | 2024 | 624 | 1.570 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 11 | 2013 | 406 | 1.370 |
Why?
|
| Regeneration | 6 | 2024 | 231 | 1.050 |
Why?
|
| Sympathetic Nervous System | 3 | 2009 | 67 | 0.890 |
Why?
|
| Heart | 6 | 2023 | 749 | 0.870 |
Why?
|
| Mitosis | 1 | 2024 | 195 | 0.870 |
Why?
|
| Phosphoproteins | 6 | 2024 | 456 | 0.810 |
Why?
|
| Homeodomain Proteins | 4 | 2018 | 584 | 0.810 |
Why?
|
| Cell Cycle Proteins | 8 | 2024 | 704 | 0.740 |
Why?
|
| Embryo, Mammalian | 7 | 2013 | 464 | 0.650 |
Why?
|
| Transcription Factors | 8 | 2024 | 2712 | 0.640 |
Why?
|
| Myocardial Infarction | 7 | 2024 | 1101 | 0.600 |
Why?
|
| Cell Proliferation | 9 | 2020 | 2554 | 0.590 |
Why?
|
| Dystrophin | 1 | 2017 | 43 | 0.550 |
Why?
|
| Neurogenesis | 2 | 2009 | 223 | 0.540 |
Why?
|
| Neural Crest | 4 | 2010 | 56 | 0.510 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 218 | 0.500 |
Why?
|
| Gene Expression Regulation, Developmental | 9 | 2019 | 1046 | 0.490 |
Why?
|
| Cytoskeleton | 2 | 2020 | 175 | 0.480 |
Why?
|
| Glycoproteins | 1 | 2017 | 379 | 0.460 |
Why?
|
| Mice, Knockout | 15 | 2018 | 3991 | 0.420 |
Why?
|
| Myoblasts, Cardiac | 1 | 2013 | 6 | 0.410 |
Why?
|
| Sulfones | 3 | 2020 | 74 | 0.410 |
Why?
|
| YY1 Transcription Factor | 1 | 2013 | 16 | 0.410 |
Why?
|
| Mice | 25 | 2024 | 18948 | 0.400 |
Why?
|
| Actins | 1 | 2015 | 350 | 0.400 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 177 | 0.370 |
Why?
|
| Signal Transduction | 10 | 2024 | 4908 | 0.370 |
Why?
|
| Pyrroles | 3 | 2020 | 187 | 0.370 |
Why?
|
| Animals | 32 | 2024 | 36421 | 0.370 |
Why?
|
| Mesoderm | 2 | 2010 | 113 | 0.350 |
Why?
|
| Norepinephrine | 2 | 2009 | 175 | 0.340 |
Why?
|
| Cell Differentiation | 5 | 2018 | 2025 | 0.320 |
Why?
|
| Smad4 Protein | 1 | 2009 | 57 | 0.320 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 3 | 2020 | 40 | 0.320 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2009 | 130 | 0.300 |
Why?
|
| Hedgehog Proteins | 2 | 2009 | 266 | 0.300 |
Why?
|
| Organogenesis | 2 | 2019 | 83 | 0.290 |
Why?
|
| Mice, Inbred mdx | 2 | 2017 | 46 | 0.260 |
Why?
|
| Autonomic Nervous System | 2 | 2005 | 50 | 0.250 |
Why?
|
| Receptors, Mineralocorticoid | 2 | 2016 | 18 | 0.250 |
Why?
|
| Heart Failure | 4 | 2023 | 2424 | 0.240 |
Why?
|
| Cells, Cultured | 5 | 2024 | 3173 | 0.230 |
Why?
|
| Sarcomeres | 1 | 2024 | 34 | 0.230 |
Why?
|
| Pericardium | 2 | 2018 | 86 | 0.220 |
Why?
|
| Yolk Sac | 1 | 2004 | 20 | 0.220 |
Why?
|
| Mice, Transgenic | 8 | 2020 | 2529 | 0.220 |
Why?
|
| Heart Defects, Congenital | 2 | 2022 | 1874 | 0.220 |
Why?
|
| Microtubules | 1 | 2024 | 131 | 0.210 |
Why?
|
| Cytoplasm | 1 | 2024 | 303 | 0.210 |
Why?
|
| Morphogenesis | 1 | 2004 | 215 | 0.200 |
Why?
|
| Cell Division | 1 | 2024 | 773 | 0.200 |
Why?
|
| Neovascularization, Physiologic | 1 | 2004 | 228 | 0.200 |
Why?
|
| beta-Galactosidase | 3 | 2010 | 150 | 0.180 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2020 | 248 | 0.180 |
Why?
|
| Mice, Inbred C57BL | 5 | 2024 | 4841 | 0.170 |
Why?
|
| Tetrazoles | 1 | 2020 | 64 | 0.170 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 1 | 2020 | 57 | 0.160 |
Why?
|
| Phosphorylation | 3 | 2020 | 1707 | 0.160 |
Why?
|
| Desoxycorticosterone Acetate | 2 | 2016 | 3 | 0.160 |
Why?
|
| DNA-Binding Proteins | 3 | 2004 | 2164 | 0.160 |
Why?
|
| Diabetic Nephropathies | 1 | 2020 | 114 | 0.160 |
Why?
|
| Organ Size | 2 | 2017 | 467 | 0.150 |
Why?
|
| Imidazoles | 1 | 2020 | 217 | 0.150 |
Why?
|
| Neurons | 4 | 2011 | 2041 | 0.150 |
Why?
|
| Prasugrel Hydrochloride | 1 | 2018 | 24 | 0.150 |
Why?
|
| Adipogenesis | 1 | 2018 | 79 | 0.140 |
Why?
|
| Fibroblasts | 2 | 2022 | 921 | 0.140 |
Why?
|
| Dystroglycans | 1 | 2017 | 7 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2010 | 1762 | 0.140 |
Why?
|
| Heart Failure, Systolic | 1 | 2017 | 36 | 0.140 |
Why?
|
| Pressure | 1 | 2017 | 136 | 0.130 |
Why?
|
| Cell Adhesion Molecules | 1 | 2018 | 254 | 0.130 |
Why?
|
| Receptor, ErbB-2 | 1 | 2020 | 559 | 0.130 |
Why?
|
| Phenotype | 2 | 2022 | 4551 | 0.130 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2017 | 66 | 0.130 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2016 | 44 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 289 | 0.130 |
Why?
|
| Heart Injuries | 1 | 2016 | 46 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 284 | 0.120 |
Why?
|
| Protein Binding | 2 | 2017 | 1844 | 0.120 |
Why?
|
| Enteric Nervous System | 3 | 2011 | 43 | 0.120 |
Why?
|
| Chromatin | 1 | 2019 | 612 | 0.120 |
Why?
|
| Helix-Loop-Helix Motifs | 2 | 2005 | 43 | 0.120 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 509 | 0.120 |
Why?
|
| Myocardium | 3 | 2016 | 1045 | 0.110 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 48 | 0.110 |
Why?
|
| Goals | 1 | 2014 | 134 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2013 | 38 | 0.100 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2013 | 18 | 0.100 |
Why?
|
| Antioxidants | 1 | 2016 | 377 | 0.100 |
Why?
|
| Thrombosis | 1 | 2018 | 540 | 0.100 |
Why?
|
| Mitochondria | 1 | 2018 | 744 | 0.100 |
Why?
|
| Neuroglia | 3 | 2011 | 216 | 0.100 |
Why?
|
| Stem Cells | 3 | 2011 | 752 | 0.100 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2013 | 88 | 0.100 |
Why?
|
| Cardiomyopathies | 1 | 2017 | 516 | 0.100 |
Why?
|
| Wound Healing | 1 | 2016 | 486 | 0.100 |
Why?
|
| Brain Mapping | 1 | 2014 | 405 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1301 | 0.090 |
Why?
|
| Cerebral Cortex | 1 | 2014 | 481 | 0.090 |
Why?
|
| Gastrointestinal Motility | 1 | 2011 | 56 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2013 | 446 | 0.090 |
Why?
|
| Lac Operon | 1 | 2010 | 96 | 0.080 |
Why?
|
| Hypertension | 2 | 2016 | 1397 | 0.080 |
Why?
|
| Cell Survival | 2 | 2010 | 889 | 0.080 |
Why?
|
| Ganglia, Sensory | 1 | 2009 | 4 | 0.080 |
Why?
|
| MicroRNAs | 2 | 2013 | 950 | 0.080 |
Why?
|
| Palate | 1 | 2009 | 16 | 0.080 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2009 | 55 | 0.080 |
Why?
|
| Integrases | 1 | 2010 | 163 | 0.080 |
Why?
|
| Endoribonucleases | 1 | 2010 | 85 | 0.080 |
Why?
|
| Tubulin | 1 | 2009 | 76 | 0.080 |
Why?
|
| Kidney | 1 | 2016 | 1418 | 0.080 |
Why?
|
| Ganglia, Spinal | 1 | 2009 | 73 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2013 | 1756 | 0.080 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2010 | 147 | 0.080 |
Why?
|
| Transcriptional Activation | 2 | 2015 | 497 | 0.070 |
Why?
|
| Epithelium | 1 | 2009 | 366 | 0.070 |
Why?
|
| Gastrointestinal Tract | 1 | 2010 | 243 | 0.070 |
Why?
|
| Cell Lineage | 3 | 2019 | 369 | 0.070 |
Why?
|
| Male | 10 | 2020 | 65850 | 0.070 |
Why?
|
| Blood Pressure | 3 | 2020 | 1420 | 0.070 |
Why?
|
| Catecholamines | 1 | 2007 | 59 | 0.070 |
Why?
|
| Single-Cell Analysis | 2 | 2022 | 356 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2018 | 1310 | 0.070 |
Why?
|
| Coronary Vessels | 1 | 2011 | 566 | 0.070 |
Why?
|
| Rats | 3 | 2024 | 3882 | 0.060 |
Why?
|
| Zebrafish Proteins | 2 | 2004 | 129 | 0.060 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2005 | 51 | 0.060 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2024 | 58 | 0.060 |
Why?
|
| Female | 9 | 2018 | 71603 | 0.050 |
Why?
|
| Acetylation | 1 | 2024 | 183 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2019 | 626 | 0.050 |
Why?
|
| Blood Vessels | 1 | 2004 | 108 | 0.050 |
Why?
|
| Cell Line | 3 | 2018 | 2841 | 0.050 |
Why?
|
| Humans | 10 | 2024 | 133705 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2004 | 185 | 0.050 |
Why?
|
| RNA, Messenger | 3 | 2017 | 2898 | 0.050 |
Why?
|
| Heart Ventricles | 2 | 2019 | 799 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2004 | 178 | 0.050 |
Why?
|
| Image Cytometry | 1 | 2022 | 12 | 0.050 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2022 | 11 | 0.050 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 149 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 4793 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2019 | 1418 | 0.050 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2022 | 158 | 0.040 |
Why?
|
| Tetralogy of Fallot | 1 | 2022 | 165 | 0.040 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2022 | 216 | 0.040 |
Why?
|
| Anticholesteremic Agents | 1 | 2003 | 245 | 0.040 |
Why?
|
| Monocytes | 1 | 2022 | 360 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2020 | 159 | 0.040 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2020 | 74 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2023 | 544 | 0.040 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2020 | 150 | 0.040 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 392 | 0.040 |
Why?
|
| Albuminuria | 1 | 2020 | 115 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2022 | 381 | 0.040 |
Why?
|
| Diploidy | 1 | 2019 | 39 | 0.040 |
Why?
|
| Hypoplastic Left Heart Syndrome | 1 | 2022 | 271 | 0.040 |
Why?
|
| Base Sequence | 2 | 2013 | 3172 | 0.040 |
Why?
|
| Electron Transport Complex IV | 1 | 2018 | 41 | 0.040 |
Why?
|
| Rats, Mutant Strains | 1 | 2018 | 15 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2019 | 111 | 0.040 |
Why?
|
| Transfection | 2 | 2015 | 1090 | 0.040 |
Why?
|
| Gene Expression Profiling | 2 | 2018 | 1917 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 462 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 714 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 2018 | 22 | 0.040 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2018 | 23 | 0.040 |
Why?
|
| Cardiomegaly | 1 | 2019 | 138 | 0.040 |
Why?
|
| Pregnancy | 2 | 2008 | 7533 | 0.040 |
Why?
|
| P-Selectin | 1 | 2018 | 80 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2019 | 115 | 0.040 |
Why?
|
| Hemostasis | 1 | 2018 | 70 | 0.040 |
Why?
|
| Platelet Aggregation | 1 | 2018 | 124 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2005 | 3754 | 0.040 |
Why?
|
| Transgenes | 1 | 2019 | 346 | 0.030 |
Why?
|
| Quality Control | 1 | 2017 | 126 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 396 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2019 | 321 | 0.030 |
Why?
|
| Insulin Resistance | 1 | 2022 | 696 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 250 | 0.030 |
Why?
|
| Collagen | 1 | 2018 | 327 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2020 | 1198 | 0.030 |
Why?
|
| Piperazines | 1 | 2018 | 257 | 0.030 |
Why?
|
| Electron Transport | 1 | 2016 | 56 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2018 | 236 | 0.030 |
Why?
|
| Free Radical Scavengers | 1 | 2016 | 57 | 0.030 |
Why?
|
| Action Potentials | 1 | 2019 | 530 | 0.030 |
Why?
|
| Disease Progression | 1 | 2022 | 2239 | 0.030 |
Why?
|
| Radioligand Assay | 1 | 2015 | 27 | 0.030 |
Why?
|
| Urological Agents | 1 | 2015 | 5 | 0.030 |
Why?
|
| Rats, Inbred WKY | 1 | 2015 | 56 | 0.030 |
Why?
|
| Spironolactone | 1 | 2015 | 21 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2018 | 503 | 0.030 |
Why?
|
| Aldosterone | 1 | 2015 | 68 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 194 | 0.030 |
Why?
|
| Adrenalectomy | 1 | 2015 | 40 | 0.030 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2016 | 131 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 1 | 2015 | 83 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 389 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 729 | 0.030 |
Why?
|
| Potassium | 1 | 2015 | 290 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2013 | 3971 | 0.030 |
Why?
|
| Sodium | 1 | 2015 | 309 | 0.030 |
Why?
|
| Functional Laterality | 1 | 2014 | 197 | 0.030 |
Why?
|
| Smad1 Protein | 1 | 2013 | 23 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2013 | 23 | 0.030 |
Why?
|
| Truncus Arteriosus, Persistent | 1 | 2013 | 18 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2013 | 295 | 0.030 |
Why?
|
| Photic Stimulation | 1 | 2014 | 234 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2013 | 81 | 0.030 |
Why?
|
| Apoptosis | 2 | 2011 | 1928 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2018 | 869 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 526 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2015 | 727 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2013 | 247 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2017 | 733 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2016 | 1043 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2015 | 814 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 410 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 544 | 0.020 |
Why?
|
| ELAV-Like Protein 2 | 1 | 2011 | 1 | 0.020 |
Why?
|
| ELAV-Like Protein 3 | 1 | 2011 | 1 | 0.020 |
Why?
|
| ELAV-Like Protein 4 | 1 | 2011 | 1 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 615 | 0.020 |
Why?
|
| Calbindin 2 | 1 | 2011 | 18 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2011 | 17 | 0.020 |
Why?
|
| S100 Calcium Binding Protein G | 1 | 2011 | 25 | 0.020 |
Why?
|
| ELAV Proteins | 1 | 2011 | 14 | 0.020 |
Why?
|
| Intercellular Junctions | 1 | 2011 | 25 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 1735 | 0.020 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2011 | 24 | 0.020 |
Why?
|
| Substance P | 1 | 2011 | 38 | 0.020 |
Why?
|
| Cell Count | 1 | 2011 | 241 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 2011 | 138 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 177 | 0.020 |
Why?
|
| Oxygen | 1 | 2014 | 582 | 0.020 |
Why?
|
| Histocytochemistry | 1 | 2010 | 98 | 0.020 |
Why?
|
| Crosses, Genetic | 1 | 2010 | 170 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2020 | 1415 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2010 | 103 | 0.020 |
Why?
|
| Colitis | 1 | 2011 | 173 | 0.020 |
Why?
|
| Synaptic Transmission | 1 | 2011 | 369 | 0.020 |
Why?
|
| Indoles | 1 | 2010 | 202 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 2297 | 0.020 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 270 | 0.020 |
Why?
|
| Colon | 1 | 2011 | 379 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2013 | 868 | 0.020 |
Why?
|
| Mutation | 2 | 2013 | 6294 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2655 | 0.020 |
Why?
|
| Digestive System | 1 | 2007 | 65 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2007 | 161 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 321 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 2805 | 0.010 |
Why?
|
| COP9 Signalosome Complex | 1 | 2004 | 13 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 53 | 0.010 |
Why?
|
| Yeasts | 1 | 2004 | 43 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 158 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2004 | 68 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2004 | 270 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 2004 | 300 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2004 | 484 | 0.010 |
Why?
|
| Hydrocarbons, Fluorinated | 1 | 2003 | 5 | 0.010 |
Why?
|
| Cell Movement | 1 | 2007 | 917 | 0.010 |
Why?
|
| ATP Binding Cassette Transporter 1 | 1 | 2003 | 22 | 0.010 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2003 | 21 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 2004 | 149 | 0.010 |
Why?
|
| Liver X Receptors | 1 | 2003 | 19 | 0.010 |
Why?
|
| Child | 1 | 2023 | 25765 | 0.010 |
Why?
|
| Receptors, LDL | 1 | 2003 | 102 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2014 | 3843 | 0.010 |
Why?
|
| Biological Transport | 1 | 2003 | 369 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2004 | 1134 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2003 | 197 | 0.010 |
Why?
|
| Lipoproteins | 1 | 2003 | 192 | 0.010 |
Why?
|
| Ligands | 1 | 2003 | 572 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 589 | 0.010 |
Why?
|
| Sulfonamides | 1 | 2003 | 286 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 573 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 9873 | 0.010 |
Why?
|
| Lipids | 1 | 2003 | 566 | 0.010 |
Why?
|
| DNA | 1 | 2004 | 1677 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 1535 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 6585 | 0.010 |
Why?
|
| Adult | 1 | 2014 | 31872 | 0.010 |
Why?
|